Dr. Andreas Saltos, MD
book an appointment
Dr. Andreas Saltos, MD
Hematology & Oncology
Dr. Andreas Saltos, MD is a hematologist oncologist in Tampa, FL. Dr. Saltos has extensive experience in Pulmonary Neoplasms. He is affiliated with Moffitt Cancer Center Magnolia Campus. He is accepting new patients and telehealth appointments.
Locations
Moffitt Cancer Center, Magnolia Campus
At a Glance
- Area of Expertise • Dr. Saltos specializes in the area of Medical Oncology. See board certifications
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
More Hematology Specialists at Moffitt Cancer Center
Experience Check
Search for experience in a specific area
Dr. Saltos' Reviews
Likelihood to recommend Dr. Saltos
5.0
| 5 Star | 100% | 100% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 0% | 0% |
| 1 Star | 0% | 0% |
Leave a review
How was your experience with Dr. Saltos?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Saltos to family and friends is 5 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
care philosophy
Dr Andreas Saltos is a Medical Oncologist and the Clinical Research Medical Director in the Department of Thoracic Oncology at Moffitt Cancer Center. Dr Saltos earned his MD from the University of Maryland School of Medicine in Baltimore. He completed...read morebiography
Dr. Andreas Saltos is a Medical Oncologist and the Clinical Research Medical Director in the Department of Thoracic Oncology at Moffitt Cancer Center. Dr. Saltos earned hHematology & Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEarly Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy, 2023-04-28
Trastuzumab Deruxtecan inHER2-Mutant Non-Small-Cell Lung Cancer, 2021-09-18
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.